KIF18B and cancer: We integrated the KIF18B mRNA level with the overall survival (OS), disease-specific survival (DSS), disease-free survival (DFI), and progression-free interval (PFI) of the 33 cancer types and used the Kaplan-Meier (KM) survival curve and Cox proportional hazards models to evaluate the effect of KIF18B on cancer prognosis.